Why Catalyst Pharmaceuticals Stock Is Sinking Today
After it announced a secondary common stock offering, shares of Catalyst Pharmaceuticals (NASDAQ: CPRX), a commercial-stage biopharma focused on rare diseases, fell as much as 16% in early-morning trading on Thursday. The stock was down about 11% as of 10:38 a.m. EST.
Here are the details of the capital raise that we know so far:
Given the current share price of about $6.60, this offering could raise about $61 million in proceeds before fees are subtracted.
Source Fool.com
